The receipt of a notice of allowance for a patent application is a positive development for any company, especially in the technology and healthcare sectors. For Movano Inc., this indicates recognition of their innovative approach to healthcare technology, specifically in the critical area of blood glucose monitoring. This could lead to increased investor confidence, potential partnerships, and a stronger position in the healthcare technology market. The direct impact on the company's stock price is likely to be positive in the short term, as the market reacts to the news of the company's strengthened intellectual property portfolio and potential for future product development and commercialization.